Furthermore, the interaction between elevated CEA levels and hepatic steatosis may synergistically enhance the proinflammatory and endothelial-damaging effects, thereby promoting the development of atherosclerotic plaques and IHD. This evidence concerns the gene CEACAM5 and myocardial ischemia.